Share
Journal Information
Most often read
970
Lessons learned after the disruption caused by COVID-19 in the management of urolithiasis: An example of adaptation in a high-volume centerA. Artiles Medina, I. Laso García, M. Mata Alcaraz, D. López Curtis, S. Arribas Terradillos, M. Hevia Palacios, G. Duque Ruiz, F. Arias Funez, F.J. Burgos Revilla
Actas Urol Esp. 2023;47:149-58
970
336
Water vapor thermal therapy: Technical variations among spanish hospitals and efficacy at 2-year follow-upI. Schwartzmann, S. García Barreras, M. D’Anna, V. Parejo, I. Torneo Ruiz, A.C. Tagalos Muñoz, A. Bravo-Balado, P. Diana, ... E. Fernández Guzmán
Actas Urol Esp. 2023;47:668-74
336
310
External validation of the current scoring systems and derivation of a novel scoring system to predict stone free rates after retrograde intrarenal surgery in patients with cumulative stone diameter of 2–4 cmS. Polat, Y.O. Danacioglu, S. Yarimoglu, M. Soytas, A. Erdogan, K. Teke, T. Degirmenci, A.I. Tasci
Actas Urol Esp. 2023;47:211-20
310
268
Clinical impact of the suspension of the ERAS protocol on patients undergoing radical cystectomy during the COVID-19 pandemicS. Castellarnau, J.M. Gaya, J. Espinosa, P. Sierra, J. Huguet, J. Palou, D. Hernando, S. Sabaté, A. Breda
Actas Urol Esp. 2023;47:369-75
268
202
Women in urology: what is their current situation in Spain?E. Seguí-Moya, A. Amorós-Torres, C. Centeno-Álvarez, G. Gutiérrez-Zurimendi, I. Nuno de la Rosa, E. Escudero-Fontano, A. Sierra del Río, M.P. Moreno-Fontela, ... C. González-Enguita
Actas Urol Esp. 2023;47:462-9
202
Full text access
Open Article
34
A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancerA. Borque-Fernando, M.A. Calleja-Hernández, J.M. Cózar-Olmo, A. Gómez-Iturriaga, D.A. Pérez-Fentes, J. Puente-Vázquez, M. Rodrigo-Aliaga, M. Unda, J.L. Álvarez-Ossorio
Actas Urol Esp. 2023;47:111-26
34
23
Initial results of endourological treatment of renoureteral lithiasis by means of flexible ureteroscopy and percutaneous surgery in an outpatient procedure in a tertiary care centerM.E. Martínez-Corral, J.J. Núñez-Otero, C. Fernández-Baltar, A. Masid-Gómez, C. Valiño-Hortas, D. Pérez-Fentes
Actas Urol Esp. 2023;47:15-21
23
23
Bladder Epicheck® for surveillance in high-risk non-muscle-invasive bladder cancer: Initial experience and follow-up proposalJ. Caño Velasco, L. Polanco Pujol, J.C. Moreno Cortés, A. Lafuente Puentedura, C. Hernández Fernández
Actas Urol Esp. 2023;47:471-3
23
11
Effectiveness and health cost analysis between immunoprophylaxis with MV140 autovaccine, MV140 vaccine and continuous treatment with antibiotics to prevent recurrent urinary tract infectionsC. Ramírez-Sevilla, E. Gómez-Lanza, J. Llopis-Manzanera, A. Cetina-Herrando, J.M. Puyol-Pallàs
Actas Urol Esp. 2023;47:27-33
11
10
Reduced- vs full-dose BCG in bladder cancer: A systematic review and meta-analysisP. Verri, M. Baboudjian, P. Diana, A. Gallioli, A. Territo, J.M. Gaya, J. Huguet, O. Rodriguez-Faba, ... A. Breda
Actas Urol Esp. 2023;47:4-14
10
9
Hormone sensitive protocol for metastatic prostate cancer, an updateJ.L. Álvarez Ossorio, M. Rodrigo Aliaga, A. Rodríguez Antolin, M. Unda Urzaiz, M.Á. Calleja, M. de la Cruz Ruiz, J. Blas Quilez, I.R. Hernández Millán, ... J.M. Cozar Olmo
Actas Urol Esp. 2023;47:244-9
9
7
Androgen deprivation therapy in localized prostate cancer. Current status and future trendsJ. Gómez Rivas, L. Fernandez, P. Abad-Lopez, J. Moreno-Sierra
Actas Urol Esp. 2023;47:398-407
7
7
Open versus robotic-assisted kidney transplantation: A systematic review by the European Association of Urology (EAU) – Young Academic Urologists (YAU) Kidney Transplant Working GroupA. Territo, A.S. Bajeot, B. Mesnard, R. Campi, A. Pecoraro, V. Hevia, A. Piana, N. Doumerc, ... T. Prudhomme
Actas Urol Esp. 2023;47:474-87
7
6
Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors’ replyA. Borque-Fernando, M.A. Calleja-Hernández, J.M. Cózar-Olmo, A. Gómez-Iturriaga, D.A. Pérez-Fentes, J. Puente-Vázquez, M. Rodrigo-Aliaga, M. Unda, J.L. Álvarez-Ossorio
Actas Urol Esp. 2023;47:392-3
6
5
Optimising the management of bone related effects of androgen deprivation therapy in prostate cancer in the non-castration resistant scenarioJ. Gómez Rivas, L. Fernandez, J. Moreno-Sierra
Actas Urol Esp. 2023;47:65-7
5
5
Impact of adipose tissue distribution on prostate cancer recurrence after radical prostatectomyD. Vertulli, D. Santucci, F. Esperto, B. Beomonte Zobel, R.F. Grasso, E. Faiella
Actas Urol Esp. 2023;47:104-10
5
5
BCG unresponsive non-muscle invasive bladder cancer: The beginning of a new era?F. Guerrero-Ramos
Actas Urol Esp. 2023;47:329-31
5
4
Deceased donor kidney procurement: Systematic review of the surgical techniqueL. Polanco Pujol, J. Caño Velasco, J. González García, F. Herranz Amo, E. Lledó García, G. Bueno Chomón, J. Mayor de Castro, J. Aragón Chamizo, ... C. Hernández Fernández
Actas Urol Esp. 2023;47:140-8
4
4
Metabolic acidosis after ileal urinary diversion and radical cystectomy. Do we know as much as we think we do? A systematic reviewA. Domínguez García, J. Muñoz Rodríguez, J. Prats López, J. Almirall Daly, C. Centeno Álvarez, L. de Verdonces Roman, C. Pla Terradellas, X. Serra Aracil
Actas Urol Esp. 2023;47:195-210
4
3
The factors that cause penile shortening after plication surgery in patients with congenital penile curvatureC. Sahin, C. Yesildal
Actas Urol Esp. 2023;47:99-103
3
Publish in
Actas Urológicas Españolas
Actas Urológicas Españolas (English Edition) is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.
Free access articles
Actas Urol Esp. 2024;48:623-31
Actas Urol Esp. 2024;48:461-9
10.1016/j.acuroe.2024.05.014